is retatrutide the same as mounjaro Retatrutide: New Triple-Agonist Weight Loss Treatment Tirzepatide vs. Retatrutide: Key Differences

GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE -/- mice

Br J Sports Med

In a recent, large clinical trial involving more than 17,000 adults living with overweight or obesity and established heart disease, participants who received a weekly semaglutide injection experienced a 20% reduction in major adverse cardiovascular events (MACE), such as heart attack and stroke, compared to those who didnt take the medication

Based on the data that 1 in 20 people in the United States are currently taking a GLP-1RA (and assuming a population of 340 million) the number of people affected in the US could be: More than 1 in 10 = at least 3,400,000 1 in 10 to 100 = ~340,000 to 3,400,000 1 in 100 to 1,000 = ~34,000 to 340,000 1 in 1,000 to 10,000 = ~3,400 to 34,000 In the US, GLP-1RAs carry a black box warning to highlight the risk of thyroid C-cell carcinomas (cancer) based on data from rodent studies

Accumulation is the hidden variable A small daily amount can produce a much larger active exposure over time because the previous dose has not cleared before the next one is added